Time period given by analyst is Intra Day when Syngene International Ltd. price can reach defined target.
Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 24969.62 Crore) operating in Pharmaceuticals sector.
Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Consolidated Total Income of Rs 623.10 Crore, up 2.69 % from last quarter Total Income of Rs 606.80 Crore and up 16.82 % from last year same quarter Total Income of Rs 533.40 Crore. Company reported net profit after tax of Rs 66.70 Crore in latest quarter.
Investment Rationale
The appearance of a large bullish candle and swift reversal from the lower levels in the recent past suggests a resumption of uptrend
Promoter/FII Holdings
Promoters held 70.42 per cent stake in the company as of 30-Sep-2021, while FIIs owned 14.23 per cent, DIIs 4.66 per cent.